Figure 8.

Indicated that after HepG2 cells were transfected LV-siMAT2A, ALV-siMAT2β and LV-siMAT2A/2β respectively, compared with control Hepatic SAMe level was decreased by LV-siMAT2A (P < 0.01), and increased by LV-siMAT2β and LV-siMAT2A/2β (P < 0.01), but there was no difference between LV-siMAT2β and LV-siMAT2A/2β.

Wang et al. Journal of Experimental & Clinical Cancer Research 2008 27:72   doi:10.1186/1756-9966-27-72
Download authors' original image